-
16350-500MLApplication Bromobenzene was used in the synthesis of four-armed star chain transfer agent required for preparation of amphiphilic star graft copolymers . Biochem/physiol Actions Bromobenzene induces hepatic necrosis via the formation of a reactive
-
B57702-100MLBromobenzene is an aryl chloride. It participates in the optimized palladium/metal oxide systems catalyzed Heck reactions of the non-activated and deactivated aryl chlorides.
-
B57702-18LBromobenzene is an aryl chloride. It participates in the optimized palladium/metal oxide systems catalyzed Heck reactions of the non-activated and deactivated aryl chlorides.
-
B57702-2LBromobenzene is an aryl chloride. It participates in the optimized palladium/metal oxide systems catalyzed Heck reactions of the non-activated and deactivated aryl chlorides.
-
B57702-500MLBromobenzene is an aryl chloride. It participates in the optimized palladium/metal oxide systems catalyzed Heck reactions of the non-activated and deactivated aryl chlorides.
-
B1552-5MGBiochem/physiol Actions Potent, irreversible inhibitor of calcium-independent phospholipase A 2 and of magnesium-dependent phosphatidate phosphohydrolase from P388D macrophages (IC 50 = 8 μM) enzyme activated irreversible chymotrypsin
-
167134-10GApplication Bromohydroquinone was used in the synthesis of Π-conjugated polymers composed of alkyl carbazole/dialkoxyphenylene and squaraine units via Sonogashira cross-coupling reactions . It was used in the preparation of 2-bromobenzoquinone
-
B75158-10GBromopentafluorobenzene
-
B75158-50GBromopentafluorobenzene
-
LC120200-L01The LabChem 0.04% w/v bromophenol ACS solution in liquid form, is soluble in water. Application: For Laboratory and Manufacturing Use Only
-
1077887-15MGThis product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the
-
72795-10MGBiochem/physiol Actions Inhibits EGFR and Src tyrosine kinase activities inhibits cAMP-dependent PDE-IV. Induces apoptosis in B16 melanoma cells and HL-60 human leukemia cells.